Apple Watch wearers rejoice! Two popular models, the Series 9 and Ultra 2, could be back on shelves sooner than expected.
A recent court ruling temporarily lifted a sales ban imposed on these watches due to a patent dispute, bringing a sigh of relief for holiday shoppers and Apple aficionados alike.
Just before Christmas, Apple faced a major setback when the International Trade Commission (ITC) ordered a halt on sales of these watches in the US. The reason? A patent infringement lawsuit filed by Masimo, a medical technology company, claiming Apple used their blood-oxygen technology without permission.
However, a federal court has stepped in and overturned the ITC’s ruling for now. This means Apple can resume selling the Series 9 and Ultra 2 models while the court considers Masimo’s appeal. This is a temporary reprieve, but it could be enough to fulfill some holiday wishlists and boost Apple’s smartwatch sales.
While the immediate concern is lifted, the legal battle is far from over. The court needs to decide whether to allow sales to continue while it hears Masimo’s appeal, which could take months. Until then, the future of these Apple Watch models hangs in the balance.
If you’ve been eyeing either the Series 9 or Ultra 2, keep an eye out for their return to retail stores and online platforms. Apple hasn’t officially announced a date, but it could happen soon. This news also serves as a reminder of the ever-evolving landscape of intellectual property disputes and their impact on consumer electronics.
This news offers a concise overview of the situation, highlighting the recent development and its potential implications. It leaves the reader informed and curious about the next chapter in this ongoing saga.
Do you have any specific questions about the affected Apple Watch models or the ongoing legal battle? I’d be happy to provide more information.